Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Trends in Neurosciences
|
May 13, 2017
Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony
Stefania Forner, David Baglietto-Vargas, Alessandra C Martini, et al.
Journal of Alzheimer'S Disease : JAD
|
March 6, 2018
Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease
Alessandra C Martini, Stefania Forner, Laura Trujillo-Estrada, et al.
Current Alzheimer Research
|
September 1, 2019
Astrocytes: From the Physiology to the Disease
Laura Trujillo-Estrada, Angela Gomez-Arboledas, Stefânia Forner, et al.
Journal of Alzheimer'S Disease : JAD
|
June 15, 2014
Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum
Laura Trujillo-Estrada, José Carlos Dávila, Elisabeth Sánchez-Mejias, et al.
The Journal of Biological Chemistry
|
April 5, 2011
Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model
Sebastian Jimenez, Manuel Torres, Marisa Vizuete, et al.
Molecular Neurodegeneration
|
November 24, 2012
Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
Manuel Torres, Sebastian Jimenez, Raquel Sanchez-Varo, et al.
Aging Cell
|
February 23, 2020
miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease
Carlos J Rodriguez-Ortiz, Gilberto Aleph Prieto, Alessandra C Martini, et al.
Acta Neuropathologica
|
October 16, 2016
Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration
Elisabeth Sanchez-Mejias, Victoria Navarro, Sebastian Jimenez, et al.
Aging Cell
|
February 28, 2019
Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models
Laura Trujillo-Estrada, Cassidy Nguyen, Celia da Cunha, et al.
Journal of Alzheimer'S Disease : JAD
|
April 24, 2010
Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus
David Baglietto-Vargas, Ines Moreno-Gonzalez, Raquel Sanchez-Varo, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Trends in Neurosciences
|
May 13, 2017
Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony
Stefania Forner, David Baglietto-Vargas, Alessandra C Martini, et al.
Journal of Alzheimer'S Disease : JAD
|
March 6, 2018
Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease
Alessandra C Martini, Stefania Forner, Laura Trujillo-Estrada, et al.
Current Alzheimer Research
|
September 1, 2019
Astrocytes: From the Physiology to the Disease
Laura Trujillo-Estrada, Angela Gomez-Arboledas, Stefânia Forner, et al.
Journal of Alzheimer'S Disease : JAD
|
June 15, 2014
Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum
Laura Trujillo-Estrada, José Carlos Dávila, Elisabeth Sánchez-Mejias, et al.
The Journal of Biological Chemistry
|
April 5, 2011
Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model
Sebastian Jimenez, Manuel Torres, Marisa Vizuete, et al.
Molecular Neurodegeneration
|
November 24, 2012
Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
Manuel Torres, Sebastian Jimenez, Raquel Sanchez-Varo, et al.
Aging Cell
|
February 23, 2020
miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease
Carlos J Rodriguez-Ortiz, Gilberto Aleph Prieto, Alessandra C Martini, et al.
Acta Neuropathologica
|
October 16, 2016
Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration
Elisabeth Sanchez-Mejias, Victoria Navarro, Sebastian Jimenez, et al.
Aging Cell
|
February 28, 2019
Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models
Laura Trujillo-Estrada, Cassidy Nguyen, Celia da Cunha, et al.
Journal of Alzheimer'S Disease : JAD
|
April 24, 2010
Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus
David Baglietto-Vargas, Ines Moreno-Gonzalez, Raquel Sanchez-Varo, et al.
Page
of 4